Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Physiol Res ; 71(S2): S219-S226, 2022 12 31.
Article in English | MEDLINE | ID: mdl-36647910

ABSTRACT

Five-sixths nephrectomy is a widely used experimental model of chronic kidney disease (CKD) that is associated with severe mitochondrial dysfunction of the remnant tissue. In this study, we assessed the effect of CKD on mitochondrial respiration separately in the rat kidney cortex and medulla 10 weeks after induction of CKD by subtotal 5/6 nephrectomy (SNX). Mitochondrial oxygen consumption was evaluated on mechanically permeabilized samples of kidney cortex and medulla using high-resolution respirometry and expressed per mg of tissue wet weight or IU citrate synthase (CS) activity. Mitochondrial respiration in the renal cortex of SNX rats was significantly reduced in all measured respiratory states if expressed per unit wet weight and remained lower if recalculated per IU citrate synthase activity, i.e. per mitochondrial mass. In contrast, the profound decrease in the activity of CS in SNX medulla resulted in significantly elevated respiratory states expressing the OXPHOS capacity when Complexes I and II or II only are provided with electrons, LEAK respiration after oligomycin injection, and Complex IV-linked oxygen consumption per unit CS activity suggesting compensatory hypermetabolic state in remaining functional mitochondria that is not sufficient to fully compensate for respiratory deficit expressed per tissue mass. The results document that CKD induced by 5/6 nephrectomy in the rat is likely to cause not only mitochondrial respiratory dysfunction (in the kidney cortex), but also adaptive changes in the medulla that tend to at least partially compensate for mitochondria loss.


Subject(s)
Kidney , Renal Insufficiency, Chronic , Rats , Animals , Citrate (si)-Synthase , Kidney/metabolism , Kidney Cortex , Mitochondria
2.
Physiol Res ; 68(Suppl 3): S233-S242, 2019 12 20.
Article in English | MEDLINE | ID: mdl-31928041

ABSTRACT

Increased activity of the sympathetic nervous system (SNS) has been proposed as a risk factor for increased cardiovascular mortality in patients with chronic kidney disease (CKD). Information on the activity of cardiac sympathetic innervation is non-homogeneous and incomplete. The aim of our study was to evaluate the tonic effect of SNS on heart rate, norepinephrine turnover and direct and indirect effects of norepinephrine in left ventricles of subtotally nephrectomized rats (SNX) in comparison with sham-operated animals (SHAM). Renal failure was verified by measuring serum creatinine and urea levels. SNX rats developed increased heart rates and blood pressure (BP). The increase in heart rate was not caused by sympathetic overactivity as the negative chronotropic effect of metipranolol did not differ between the SNX and SHAM animals. The positive inotropic effects of norepinephrine and tyramine on papillary muscle were not significantly different. Norepinephrine turnover was measured after the administration of tyrosine hydroxylase inhibitor, pargyline, tyramine, desipramine, and KCl induced depolarization. The absolute amount of released norepinephrine was comparable in both groups despite a significantly decreased norepinephrine concentration in the cardiac tissue of the SNX rats. We conclude that CKD associated with renal denervation in rats led to adaptive changes characterized by an increased reuptake and intracellular norepinephrine turnover which maintained normal reactivity of the heart to sympathetic stimulation.


Subject(s)
Cardiovascular Diseases/etiology , Heart Ventricles/metabolism , Neuropeptide Y/metabolism , Norepinephrine/blood , Renal Insufficiency, Chronic/metabolism , Animals , Calcitonin Gene-Related Peptide/metabolism , Disease Models, Animal , Heart Rate , Heart Ventricles/physiopathology , Kidney/metabolism , Male , Nephrectomy , Rats, Wistar , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/physiopathology , Sympathetic Nervous System/physiopathology
3.
Physiol Res ; 67(Suppl 4): S619-S631, 2018 12 31.
Article in English | MEDLINE | ID: mdl-30607969

ABSTRACT

Mesenchymal stem cells (MSCs) have been reported to improve survival of cardiomyocytes (CMCs) and overall regeneration of cardiac tissue. Despite promising preclinical results, interactions of MSCs and CMCs, both direct and indirect, remain unclear. In this study, porcine bone marrow MSCs and freshly isolated porcine primary adult CMCs were used for non-contact co-culture experiments. Morphology, viability and functional parameters of CMCs were measured over time and compared between CMCs cultured alone and CMCs co-cultured with MSCs. In non-contact co-culture, MSCs improved survival of CMCs. CMCs co-cultured with MSCs maintained CMCs morphology and viability in significantly higher percentage than CMCs cultured alone. In viable CMCs, mitochondrial respiration was preserved in both CMCs cultured alone and in CMCs co-cultured with MSCs. Comparison of cellular contractility and calcium handling, measured in single CMCs, revealed no significant differences between viable CMCs from co-culture and CMCs cultured alone. In conclusion, non-contact co-culture of porcine MSCs and CMCs improved survival of CMCs with a sufficient preservation of functional and mitochondrial parameters.


Subject(s)
Mesenchymal Stem Cells/physiology , Mitochondria/physiology , Myocytes, Cardiac/physiology , Age Factors , Animals , Cell Survival/physiology , Coculture Techniques/methods , Flow Cytometry/methods , Swine
4.
Br J Pharmacol ; 165(2): 467-78, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21718297

ABSTRACT

BACKGROUND AND PURPOSE: Drug development requires the testing of new chemical entities for adverse effects. For cardiac safety screening, improved assays are urgently needed. Isolated adult cardiomyocytes (CM) and human embryonic stem cell-derived cardiomyocytes (hESC-CM) could be used to identify pro-arrhythmic compounds. In the present study, five assays were employed to investigate their sensitivity and specificity for evaluating the pro-arrhythmic properties of I(Kr) blockers, using moxifloxacin (safe compound) and dofetilide or E-4031 (unsafe compounds). EXPERIMENTAL APPROACH: Assays included the anaesthetized remodelled chronic complete AV block (CAVB) dog, the anaesthetized methoxamine-sensitized unremodelled rabbit, multi-cellular hESC-CM clusters, isolated CM obtained from CAVB dogs and isolated CM obtained from the normal rabbit. Arrhythmic outcome was defined as Torsade de Pointes (TdP) in the animal models and early afterdepolarizations (EADs) in the cell models. KEY RESULTS: At clinically relevant concentrations (5-12 µM), moxifloxacin was free of pro-arrhythmic properties in all assays with the exception of the isolated CM, in which 10 µM induced EADs in 35% of the CAVB CM and in 23% of the rabbit CM. At supra-therapeutic concentrations (≥100 µM), moxifloxacin was pro-arrhythmic in the isolated rabbit CM (33%), in the hESC-CM clusters (18%), and in the methoxamine rabbit (17%). Dofetilide and E-4031 induced EADs or TdP in all assays (50-83%), and the induction correlated with a significant increase in beat-to-beat variability of repolarization. CONCLUSION AND IMPLICATIONS: Isolated cardiomyocytes lack specificity to discriminate between TdP liability of the I(Kr) blocking drugs moxifloxacin and dofetilide or E4031.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Aza Compounds/pharmacology , Myocytes, Cardiac/drug effects , Phenethylamines/pharmacology , Piperidines/pharmacology , Potassium Channel Blockers/pharmacology , Pyridines/pharmacology , Quinolines/pharmacology , Sulfonamides/pharmacology , Torsades de Pointes/chemically induced , Action Potentials/drug effects , Animals , Cell Line , Disease Models, Animal , Dogs , Embryonic Stem Cells/cytology , Female , Fluoroquinolones , Heart/drug effects , Heart/physiopathology , Heart Block/physiopathology , Humans , Methoxamine , Moxifloxacin , Myocytes, Cardiac/physiology , Rabbits , Torsades de Pointes/physiopathology , Ventricular Remodeling/drug effects
5.
Physiol Res ; 60(3): 531-40, 2011.
Article in English | MEDLINE | ID: mdl-21401302

ABSTRACT

Vasoactive intestinal peptide (VIP) is a neuropeptide released from the autonomic nerves exerting multiple antiinflammatory effects. The aim of the present study was to investigate the impact of severe sepsis and hemofiltration in two settings on plasma and tissue concentrations of VIP in a porcine model of sepsis. Thirty-two pigs were divided into 5 groups: 1) control group; 2) control group with conventional hemofiltration; 3) septic group; 4) septic group with conventional hemofiltration; 5) septic group with high-volume hemofiltration. Sepsis induced by faecal peritonitis continued for 22 hours. Hemofiltration was applied for the last 10 hours. Hemodynamic, inflammatory and oxidative stress parameters (heart rate, mean arterial pressure, cardiac output, systemic vascular resistance, plasma concentrations of tumor necrosis factor-alpha, interleukin-6, thiobarbituric acid reactive species, nitrate + nitrite, asymmetric dimethylarginine) and the systemic VIP concentrations were measured before faeces inoculation and at 12 and 22 hours of peritonitis. VIP tissue levels were determined in the left ventricle, mesenteric and coronary arteries. Sepsis induced significant increases in VIP concentrations in the plasma and mesenteric artery, but it decreased peptide levels in the coronary artery. Hemofiltration in both settings reduced concentrations of VIP in the mesenteric artery. In severe sepsis, VIP seems to be rapidly depleted from the coronary artery and, on the other hand, upregulated in the mesenteric artery. Hemofiltration in both settings has a tendency to drain away these upregulated tissue stores which could result in the limited secretory capacity of the peptide.


Subject(s)
Hemofiltration , Peritonitis/complications , Sepsis/metabolism , Vasoactive Intestinal Peptide/metabolism , Animals , Coronary Vessels/metabolism , Female , Male , Mesenteric Arteries/metabolism , Oxidative Stress , Sepsis/etiology , Sepsis/physiopathology , Swine , Vasoactive Intestinal Peptide/blood , Vasoactive Intestinal Peptide/genetics
6.
Physiol Res ; 59 Suppl 1: S81-S88, 2010.
Article in English | MEDLINE | ID: mdl-20626224

ABSTRACT

Chronic renal failure (CRF) is associated with high incidence of cardiovascular complications. To clarify pathogenesis of CRF numerous animal models have been developed. The aim of our work was to describe methodology of subtotal surgical renal ablation in rat and to characterize some biochemical and cardiovascular parameters of this animal model. Male rats underwent 5/6 surgical nephrectomy or sham operations in two steps. The following parameters were measured on day 10 and in week 10 after the surgery: plasma concentrations of creatinine and urea, blood pressure, resting heart rate, chronotropic response to atropine and metipranol, heart ventricles weight, contraction parameters and action potential duration in the left ventricle. Increased serum concentrations of creatinine and urea, decreased creatinine clearance, polyuria and alteration of the remnant kidney tissue were found in CRF rats. Changes in cardiovascular parameters identified after subtotal nephrectomy resembled alterations of cardiovascular system in uremic patients and included hypertension, elevated resting heart rate, diminished parasympathetic cardiac tone, hypertrophy of the left ventricle associated with weakened force of contraction, prolonged contraction and relaxation and shortening of action potential duration. These data suggest that the present model can be a useful tool in the study of CRF and its cardiovascular complications.


Subject(s)
Cardiovascular Diseases/etiology , Cardiovascular System/physiopathology , Hemodynamics , Kidney Failure, Chronic/complications , Action Potentials , Adrenergic beta-Antagonists/pharmacology , Animals , Atropine/pharmacology , Biomarkers/blood , Blood Pressure , Cardiovascular Diseases/physiopathology , Cardiovascular System/drug effects , Creatinine/blood , Disease Models, Animal , Heart Rate , Hemodynamics/drug effects , Kidney Failure, Chronic/physiopathology , Male , Metipranolol/pharmacology , Muscarinic Antagonists/pharmacology , Myocardial Contraction , Nephrectomy , Rats , Rats, Wistar , Time Factors , Urea/blood , Ventricular Function, Left
7.
Br J Pharmacol ; 159(7): 1532-41, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20180941

ABSTRACT

BACKGROUND AND PURPOSE: Pentamidine is a drug used in treatment of protozoal infections. Pentamidine treatment may cause sudden cardiac death by provoking cardiac arrhythmias associated with QTc prolongation and U-wave alterations. This proarrhythmic effect was linked to inhibition of hERG trafficking, but not to acute block of ion channels contributing to the action potential. Because the U-wave has been linked to the cardiac inward rectifier current (I(K1)), we examined the action and mechanism of pentamidine-mediated I(K1) block. EXPERIMENTAL APPROACH: Patch clamp measurements of I(K1) were made on cultured adult canine ventricular cardiomyocytes, K(IR)2.1-HEK293 cells and K(IR)2.x inside-out patches. Pentamidine binding to cytoplasmic amino acid residues of K(IR)2.1 channels was studied by molecular modelling. KEY RESULTS: Pentamidine application (24 h) decreased I(K1) in cultured canine cardiomyocytes and K(IR)2.1-HEK293 cells under whole cell clamp conditions. Pentamidine inhibited I(K1) in K(IR)2.1-HEK293 cells 10 min after application. When applied to the cytoplasmic side under inside-out patch clamp conditions, pentamidine block of I(K1) was acute (IC(50)= 0.17 microM). Molecular modelling predicted pentamidine-channel interactions in the cytoplasmic pore region of K(IR)2.1 at amino acids E224, D259 and E299. Mutation of these conserved residues to alanine reduced pentamidine block of I(K1). Block was independent of the presence of spermine. K(IR)2.2, and K(IR)2.3 based I(K1) was also sensitive to pentamidine blockade. CONCLUSIONS AND IMPLICATIONS: Pentamidine inhibits cardiac I(K1) by interacting with three negatively charged amino acids in the cytoplasmic pore region. Our findings may provide new insights for development of specific I(K1) blocking compounds.


Subject(s)
Antiprotozoal Agents/pharmacology , Cytoplasm/drug effects , Pentamidine/pharmacology , Potassium Channels, Inwardly Rectifying/antagonists & inhibitors , Animals , Blotting, Western , Cell Line , Cytoplasm/metabolism , Dogs , Humans , Mutation , Patch-Clamp Techniques , Potassium Channels, Inwardly Rectifying/genetics
8.
Physiol Res ; 57(4): 507-515, 2008.
Article in English | MEDLINE | ID: mdl-17705677

ABSTRACT

The contribution of the sympathetic innervation to the postnatal development of cardiac contractility remains unclear. In this study, the postnatal maturation of cardiac contractility was compared in control rats and rats after chemical sympathectomy. The chemical sympathectomy was induced by administration of 6-hydroxydopamine to newborn rats. At days 20, 40 and 60 of postnatal life, the contractile parameters and concentrations of sympathetic neurotransmitters were measured in both right and left ventricles. In rats with chemical sympathectomy, concentrations of norepinephrine were reduced almost completely in both ventricles at all time points. The contractility of the left ventricle papillary muscles was substantially decreased at all time points. In contrast, the contractility of the right ventricle papillary muscles was decreased only transiently, showing a recovery at day 60 regardless of the permanently decreased concentration of norepinephrine. The concentration of neuropeptide Y, another neurotransmitter present in sympathetic nerves, showed the same developmental trend as contractility: permanent reduction in the left ventricle, transient reduction with a recovery at day 60 in the right ventricle. The data indicate that the sympathetic nervous system plays an important role in the postnatal development of cardiac contractility and neuropeptide Y may contribute to this effect.


Subject(s)
Animals, Newborn/physiology , Myocardial Contraction/physiology , Sympathectomy, Chemical , Adrenergic alpha-Agonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Aging/physiology , Animals , Neuropeptide Y/metabolism , Norepinephrine/metabolism , Oxidopamine , Papillary Muscles/physiology , Propranolol/pharmacology , Rats , Rats, Wistar , Tyramine/pharmacology , Ventricular Function, Left/physiology , Ventricular Function, Right/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...